| Somers, Tamara J |
Duke University
United States |
A Mobile Health Behavioral Pain Intervention Protocol for Breast Cancer Patients with Pain in Medically Underserved Communities: A Randomized Controlled Trial |
5R01CA237892-05 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Sohl, Stephanie Jean |
Wake Forest University Health Sciences
United States |
REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) |
5R01CA266995-02 |
PAR-21-035 (R01 Clinical Trial Required) |
Goli Samimi, Ph.D., M.P.H. |
| Snyder, Michael P. |
Stanford University
United States |
Precancer Atlas of Familial Adenomatous Polyposis |
3U2CCA233311-01S1 |
|
Richard Mazurchuk, Ph.D. |
| Snyder, Michael P. |
Stanford University
United States |
Precancer Atlas of Familial Adenomatous Polyposis |
3U2CCA233311-01S1 |
|
Richard Mazurchuk, Ph.D. |
| Snyder, Michael P. |
Stanford University
United States |
Precancer Atlas of Familial Adenomatous Polyposis |
3U2CCA233311-01S1 |
|
Richard Mazurchuk, Ph.D. |
| Snyder, Michael P. |
Stanford University
United States |
Precancer Atlas of Familial Adenomatous Polyposis |
3U2CCA233311-01S1 |
|
Richard Mazurchuk, Ph.D. |
| Smith, Ellen Mary Lavoie |
University Of Alabama At Birmingham
United States |
Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study |
5R01CA235726-07 |
|
Brennan Streck, Ph.D., R.N., M.P.H. |
| Smith, Jennifer Susan |
Univ Of North Carolina Chapel Hill
United States |
UNC CASCADE Network Research Base |
5UG1CA275403-02 |
|
Silvina Frech, Ph.D., M.S. |
| Smalley, Keiran |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Defining and targeting the epigenetic programs involved in melanoma development |
5R21CA267141-02 |
PAR-20-292 (R21 Clinical Trial Optional) |
Winfred Malone, Ph.D., M.P.H. |
| Slager, Susan L |
Mayo Clinic Rochester
United States |
The genetic and epigenetic etiology of progression from the precursor state to chronic lymphocytic leukemia (CLL) |
5R01CA258465-02 |
|
|